Cite
HARVARD Citation
Birkeland, K. et al. (2019). How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study. Diabetes, obesity & metabolism. 21 (4), pp. 968-974. [Online].